NEWS & PRESS
Featured News
12.2021 / Press release
Eligo announces successful outcome in US CRISPR patent interference against SNIPR Biome
02.2022 / Article
ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
Featured Press & Media
All News & Press
06.2021 / Press release
Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression
03.2021 / Press release
Eligo Bioscience strengthens leadership with the appointment of former GSK R&D Executive, Dr. Hessel, as Chief Scientific Officer
06.2020 / Press release
CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients
10.2018 / Les Echos
Eligo is listed among the 10 French startups shaping the future of Healthcare